Article
Genetic testing and screening of individuals at risk of NF2.
Clinical genetics - 1 Nov 2012
Evans D G, Raymond F L, Barwell J G, Halliday D
Abstract excerpt
Genetic testing and management of the at-risk individual for neurofibromatosis type 2 (NF2) is complicated by the well-documented risk of mosaicism that causes a milder later onset more asymmetrical disease course. Risks of NF2 were derived from genetic testing of over 1000 individuals through the Manchester NF2-testing service. Individuals are at risk of NF2 or have 'potential' NF2 if they have features of the...
Topics
- Adult
- Chromosomes, Human, Pair 22
- England
- Genes, Neurofibromatosis 2
- Genetic Testing
- Humans
- Magnetic Resonance Imaging
- Middle Aged
- Mosaicism
- Mutation
- Neurofibromatosis 2
- Practice Guidelines as Topic
